International Governance of Biotechnology: Needs, Problems and Potential
By (Author) Dr. Catherine Rhodes
Bloomsbury Publishing PLC
Bloomsbury Academic
1st December 2010
United Kingdom
Professional and Scholarly
Non Fiction
Manufacturing industries
Biotechnology
343.0786606
Hardback
224
Width 156mm, Height 234mm, Spine 21mm
505g
This book is available as open access through the Bloomsbury Open Access programme and is available on www.bloomsburycollections.com. The significant media coverage recently given to issues such as the international impacts of biofuel production policies, advances in synthetic biology, and the ethical implications of research involving embryonic stem cells, is indicative of the high-level of interest - among policy-makers, academics and the public - in the biotechnology revolution, its applications, impacts and control. There is also significant interest in international regulatory processes as a form of governance, and international regulation is a vital part of efforts to manage the impacts of the biotechnology revolution, since many of these are global in their nature. The book establishes the need for international regulation of biotechnology, identifying the roles it needs to play, and the issues it needs to cover. Having outlined the importance of coherence to the effective functioning of international regulatory sets, a model of coherent international regulation is established, against which the biotechnology regulations can be assessed. This book approaches the subject from an international relations perspective but also draws from, and will contribute to, literature in the fields of international law, global governance, technological governance, and science-society relations.
Catherine Rhodes is a Research Fellow at the Institute for Science, Ethics and Innovation at the University of Manchester. She was previously Research Fellow at the Bradford Disarmament Research Centre, Departments of Peace Studies, Bradford University. She has also been a Visiting Fellow at the Brocher Foundation, Geneva and worked as a regulatory consultant for LG Ltd on a major European Commission project on biotechnology regulation.